Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Synaptic Pathology in the Cerebellar Dentate Nucleus in Chronic Multiple Sclerosis.
Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.
N-Oxides rescue Ru(v) in catalytic Griffith-Ley (TPAP) alcohol oxidations.
Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis.
Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis.
[Response to treatment with interferon beta in patients with multiple sclerosis. Validation of the Rio Score].
The crucial role of Erk2 in demyelinating inflammation in the central nervous system.
Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies.
Resilience Mediates the Longitudinal Relationships Between Social Support and Mental Health Outcomes in Multiple Sclerosis.
Paediatric brainstem: A comprehensive review of pathologies on MR imaging.
Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.
On the evolution of myelin.
Preterm white matter brain injury is prevented by early administration of umbilical cord blood cells.
Comment on the article by Allen et al. 'A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers'
Predictors of static balance in ambulatory persons with multiple sclerosis.
CYP4F2 affects phenotypic outcome in adrenoleukodystrophy by modulating the clearance of very long-chain fatty acids.
Evaluation of Patients with Refractory Chronic Inflammatory Demyelinating Polyneuropathy.
Diffusivity in multiple sclerosis lesions: At the cutting edge?
Cerebrospinal fluid cytokines in Lyme neuroborreliosis.
Human leucocyte antigen (HLA) class I and II typing in Belgian multiple sclerosis patients.
Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.
Inflammatory Th17 Cells Express Integrin αvβ3 for Pathogenic Function.
Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD.
Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis.
Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application.

Pages